BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10832027)

  • 1. Characterization of chloroquine-hematin mu-oxo dimer binding by isothermal titration calorimetry.
    Vippagunta SR; Dorn A; Ridley RG; Vennerstrom JL
    Biochim Biophys Acta; 2000 Jul; 1475(2):133-40. PubMed ID: 10832027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth.
    Vippagunta SR; Dorn A; Matile H; Bhattacharjee AK; Karle JM; Ellis WY; Ridley RG; Vennerstrom JL
    J Med Chem; 1999 Nov; 42(22):4630-9. PubMed ID: 10579825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine.
    Vippagunta SR; Dorn A; Bubendorf A; Ridley RG; Vennerstrom JL
    Biochem Pharmacol; 1999 Sep; 58(5):817-24. PubMed ID: 10449192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple spectroscopic and magnetic techniques show that chloroquine induces formation of the μ-oxo dimer of ferriprotoporphyrin IX.
    Kuter D; Benjamin SJ; Egan TJ
    J Inorg Biochem; 2014 Apr; 133():40-9. PubMed ID: 24480793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structures of chloroquine-ferriheme complexes modeled using MD simulation and investigated by EXAFS spectroscopy.
    Kuter D; Streltsov V; Davydova N; Venter GA; Naidoo KJ; Egan TJ
    J Inorg Biochem; 2016 Jan; 154():114-25. PubMed ID: 26088729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregated enhanced Raman scattering in Fe(III)PPIX solutions: the effects of concentration and chloroquine on excitonic interactions.
    Webster GT; McNaughton D; Wood BR
    J Phys Chem B; 2009 May; 113(19):6910-6. PubMed ID: 19371036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.
    Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ
    Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon isosteres of the 4-aminopyridine substructure of chloroquine: effects on pK(a), hematin binding, inhibition of hemozoin formation, and parasite growth.
    Cheruku SR; Maiti S; Dorn A; Scorneaux B; Bhattacharjee AK; Ellis WY; Vennerstrom JL
    J Med Chem; 2003 Jul; 46(14):3166-9. PubMed ID: 12825955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of chloroquine and its analogues with heme: An isothermal titration calorimetric study.
    Bachhawat K; Thomas CJ; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1075-9. PubMed ID: 11027592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structures of antimalarial drug-heme complexes.
    Leed A; DuBay K; Ursos LM; Sears D; De Dios AC; Roepe PD
    Biochemistry; 2002 Aug; 41(32):10245-55. PubMed ID: 12162739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of quinoline antimalarials with hematin in solution.
    Egan TJ
    J Inorg Biochem; 2006 May; 100(5-6):916-26. PubMed ID: 16384600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of antimalarial action of the ruthenium(II)-chloroquine complex [RuCl(2)(CQ)] (2).
    Martínez A; Rajapakse CS; Naoulou B; Kopkalli Y; Davenport L; Sánchez-Delgado RA
    J Biol Inorg Chem; 2008 Jun; 13(5):703-12. PubMed ID: 18305967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinine and chloroquine differentially perturb heme monomer-dimer equilibrium.
    Casabianca LB; An D; Natarajan JK; Alumasa JN; Roepe PD; Wolf C; de Dios AC
    Inorg Chem; 2008 Jul; 47(13):6077-81. PubMed ID: 18533646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speciation of ferriprotoporphyrin IX in aqueous and mixed aqueous solution is controlled by solvent identity, pH, and salt concentration.
    Asher C; de Villiers KA; Egan TJ
    Inorg Chem; 2009 Aug; 48(16):7994-8003. PubMed ID: 19572726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX, a solid state spectroscopy study.
    Asghari-Khiavi M; Vongsvivut J; Perepichka I; Mechler A; Wood BR; McNaughton D; Bohle DS
    J Inorg Biochem; 2011 Dec; 105(12):1662-9. PubMed ID: 22079977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
    Olafson KN; Ketchum MA; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4946-51. PubMed ID: 25831526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hydroxyl functionality and a rigid proximal N are required for forming a novel non-covalent quinine-heme complex.
    Alumasa JN; Gorka AP; Casabianca LB; Comstock E; de Dios AC; Roepe PD
    J Inorg Biochem; 2011 Mar; 105(3):467-75. PubMed ID: 20864177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
    Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
    ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs.
    Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D
    Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.
    Olafson KN; Nguyen TQ; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7531-7536. PubMed ID: 28559329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.